North Carolina Attorney General Jeff Jackson and State Treasurer Brad Briner on Thursday announced the terms of a settlement with an EpiPen manufacturer that will bring the state millions.<\/p>\n
Jackson said the company that sold the EpiPens, Mylan, participated in anti-competitive practices that allowed them to raise the price and overcharge for their product. A settlement will mean a refund for some in our state.<\/p>\n
“From 2007 to 2016, the price of this went from about $100 to about $600, a 6X increase in under a decade,” Jackson said while holding an EpiPen.\u00a0<\/p>\n
The terms of the settlement determine that the state will get $11 million with a big chunk of that going to taxpayers.<\/p>\n
“We also negotiated a reduction in out-of-pocket costs for all families going forward,” Jackson said. “This is a very important message to send to prescription drug manufacturers everywhere, that if we have good evidence that you’ve broken the law, we’re going to hold you accountable.”\u00a0<\/p>\n
“As someone who carries an EpiPen and someone who has a child who carries an EpiPen, this particularly hits close to home for me,” Briner said. <\/p>\n
$4.2 million of this settlement comes to the state health plan … this money belongs to the people of North Carolina, it’ll go right back to keeping premiums down.”<\/p>\n
This isn’t the first instance of a lawsuit against Mylan in our state. In 2017, then-Attorney General Josh Stein announced the state would settle with Mylan for $21.4 million. The most recent lawsuit was launched after the previous class action suit was settled.<\/p>\n
Mylan has since merged with Pfizer’s Upjohn business in 2020 to form Viatris.<\/p>\n","protected":false},"excerpt":{"rendered":"North Carolina Attorney General Jeff Jackson and State Treasurer Brad Briner on Thursday announced the terms of a…\n","protected":false},"author":3,"featured_media":764531,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[105728,207710,210,3270,61023,379,1060,148913,11825,10495,67,132,68],"class_list":["post-764530","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-5-on-your-side","tag-epipen","tag-health","tag-health-care-costs","tag-jeff-jackson","tag-lawsuit","tag-medication","tag-nccapitol","tag-prescription-drugs","tag-settlement","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116495965937997100","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/764530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=764530"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/764530\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/764531"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=764530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=764530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=764530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}